Identification of a Disease-Causing Mutation in a Chinese Patient with Retinitis Pigmentosa by Targeted Next-Generation Sequencing

Abstract

Purpose

To identify disease-causing mutations in a Chinese patient with retinitis pigmentosa (RP).

Methods

A detailed clinical examination was performed on the proband. Targeted next-generation sequencing (NGS) combined with bioinformatics analysis was performed on the proband to detect candidate disease-causing mutations. Sanger sequencing was performed on all subjects to confirm the candidate mutations and assess cosegregation within the family.

Results

Clinical examinations of the proband showed typical characteristics of RP. Three candidate heterozygous mutations in 3 genes associated with RP were detected in the proband by targeted NGS. The 3 mutations were confirmed by Sanger sequencing and the deletion (c.357_358delAA) in PRPF31 was shown to cosegregate with RP phenotype in 7 affected family members, but not in 3 unaffected family members.

Conclusions

The deletion (c.357_358delAA) in PRPF31 was the disease-causing mutation for the proband and his affected family members with RP. To our knowledge, this is the second report of the deletion and the first report of the other 2 mutations in the Chinese population. Targeted NGS combined with bioinformatics analysis proved to be an effective molecular diagnostic tool for RP.

Keywords

Retinitis pigmentosa Targeted next-generation sequencing

Get full access to this article

View all access options for this article.

References

Veltel

Gasper

Eisenacher

Wittinghofer

The retinitis pigmentosa 2 gene product is a GTPase-activating protein for Arf-like 3.

Nat Struct Mol Biol. 2008;15(4):373–380.

Daiger

Bowne

Sullivan

Perspective on genes and mutations causing retinitis pigmentosa.

Arch Ophthalmol. 2007;125(2):151–158.

Kajiwara

Berson

Dryja

Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci.

Science. 1994;264(5165):1604–1608.

Hims

Diager

Inglehearn

Retinitis pigmentosa: genes, proteins and prospects.

Dev Ophthalmol. 2003;37:109–125.

Liu

Wei

Kong

et al.

Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases

[erratum at http://dx.doi.org/10.1371/journal.pone.0139258]. PLoS One. 2015;10(8):e0133636.

Wei

Sun

Xie

et al.

Next-generation sequencing identifies a novel compound heterozygous mutation in MYO7A in a Chinese patient with Usher Syndrome 1B.

Clin Chim Acta. 2012;413(23-24):1866–1871.

Wei

et al.

Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing.

PLoS One. 2011;6(12):e29500.

al-Maghtheh

Inglehearn

Keen

et al.

Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19.

Hum Mol Genet. 1994;3(2):351–354.

Daiger

Sullivan

Gire

Birch

Heckenlively

Bowne

Mutations in known genes account for 58% of autosomal dominant retinitis pigmentosa (adRP).

Adv Exp Med Biol. 2008;613:203–209.

10.

Rio Frio

Wade

Ransijn

Berson

Beckmann

Rivolta

Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay.

J Clin Invest. 2008;118(4):1519–1531.

11.

Faustino

Cooper

Pre-mRNA splicing and human disease.

Genes Dev. 2003;17(4):419–437.

12.

Deery

Vithana

Newbold

et al.

Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31.

Hum Mol Genet. 2002;11(25):3209–3219.

13.

Gandra

Anandula

Authiappan

et al.

Retinitis pigmentosa: mutation analysis of RHO, PRPF31, RP1, and IMPDH1 genes in patients from India.

Mol Vis. 2008;14:1105–1113.

14.

Audo

Bujakowska

Mohand-Saïd

et al.

Prevalence and novelty of PRPF31 mutations in French autosomal dominant rod-cone dystrophy patients and a review of published reports.

BMC Med Genet. 2010;11:145.

15.

Yang

Tian

Lee

et al.

Clinical and genetic identification of a large chinese family with autosomal dominant retinitis pigmentosa.

Ophthalmic Genet. 2015;36(1):64–69.

16.

Sakuma

Inana

Murakami

et al.

A heterozygous putative null mutation in ROM1 without a mutation in peripherin/RDS in a family with retinitis pigmentosa.

Genomics. 1995;27(2):384–386.

17.

Bascom

Liu

Heckenlively

Stone

McInnes

Mutation analysis of the ROM1 gene in retinitis pigmentosa.

Hum Mol Genet. 1995;4(10):1895–1902.

18.

Jinda

Taylor

Suzuki

et al.

Whole exome sequencing in Thai patients with retinitis pigmentosa reveals novel mutations in six genes.

Invest Ophthalmol Vis Sci. 2014;55(4):2259–2268.

19.

Zhao

Hosono

Suto

et al.

The first USH2A mutation analysis of Japanese autosomal recessive retinitis pigmentosa patients: a totally different mutation profile with the lack of frequent mutations found in Caucasian patients.

J Hum Genet. 2014;59(9):521–528.

20.

Liquori

Vaché

Baux

et al.

Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations.

Hum Mutat. 2016;37(2):184–193.

21.

Huang

et al.

Identification of false-negative mutations missed by next-generation sequencing in retinitis pigmentosa patients: a complementary approach to clinical genetic diagnostic testing.

Genet Med. 2015;17(4):307–11.

22.

Huang

Mao

Huang

et al.

Genome-Wide Detection of Copy Number Variations in Unsolved Inherited Retinal Disease.

Invest Ophthalmol Vis Sci. 2017;58(1):424–429.

23.

Huang

et al.

Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing.

Genet Med. 2015;17(4):271–8.

24.

Guan

Shen

et al.

Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing.

Hum Genet. 2014;133(10):1255–1271.